Skip to main content

Boston Scientific Neuromodulation revenue

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$44.34+0.32%Close 13 Nov 2026 · Market value $63.59B

Neuromodulation revenue at Boston Scientific came to $331.0M for the quarter to 30 Sep 2026, up 13.0% from a year earlier.

As Boston Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 2 Nov 2026.

By quarter

$268.0MDec 2023$256.0MMar 2024$282.0MJun 2024$268.0MSep 2024$299.0MDec 2024$271.0MMar 2025$303.0MJun 2025$293.0MSep 2025$333.0MDec 2025$318.0MMar 2026$341.0MJun 2026$331.0MSep 2026
Boston Scientific Neuromodulation revenue, every reported period
Period endingNeuromodulation revenueChange on a yearFiled
30 Sep 2026$331.0Mup 13.0%2 Nov 2026
30 Jun 2026$341.0Mup 12.5%3 Aug 2026
31 Mar 2026$318.0Mup 17.3%1 May 2026
31 Dec 2025$333.0Mup 11.4%17 Feb 2026
30 Sep 2025$293.0Mup 9.3%3 Nov 2025
30 Jun 2025$303.0Mup 7.4%1 Aug 2025
31 Mar 2025$271.0Mup 5.9%1 May 2025
31 Dec 2024$299.0Mup 11.6%18 Feb 2025
30 Sep 2024$268.0Mup 17.0%1 Nov 2024
30 Jun 2024$282.0Mup 15.6%1 Aug 2024
31 Mar 2024$256.0Mup 9.4%1 May 2024
31 Dec 2023$268.0Mup 8.1%20 Feb 2024
30 Sep 2023$229.0Mup 3.6%1 Nov 2023
30 Jun 2023$244.0Mup 2.1%3 Aug 2023
31 Mar 2023$234.0Mup 12.0%4 May 2023
31 Dec 2022$248.0Mup 2.1%23 Feb 2023
30 Sep 2022$221.0Munchanged3 Nov 2022
30 Jun 2022$239.0Mdown 3.2%4 Aug 2022
31 Mar 2022$209.0Mup 5.6%5 May 2022
31 Dec 2021$243.0Mup 4.7%23 Feb 2022
30 Sep 2021$221.0Mup 2.3%4 Nov 2021
30 Jun 2021$247.0Mup 102.5%6 Aug 2021
31 Mar 2021$198.0Mup 3.7%6 May 2021
31 Dec 2020$232.0Mdown 11.1%23 Feb 2021
30 Sep 2020$216.0Mdown 2.7%5 Nov 2020
30 Jun 2020$122.0Mdown 40.2%5 Aug 2020
31 Mar 2020$191.0Mup 2.7%6 May 2020
31 Dec 2019$261.0Mup 18.6%25 Feb 2020
30 Sep 2019$222.0Mup 17.5%5 Nov 2019
30 Jun 2019$204.0Mup 1.0%30 Jul 2019
31 Mar 2019$186.0Mup 10.1%29 Apr 2019
31 Dec 2018$220.0Mup 18.3%19 Feb 2019
30 Sep 2018$189.0Mup 22.7%29 Oct 2018
30 Jun 2018$202.0Mup 31.2%31 Jul 2018
31 Mar 2018$169.0Mup 19.9%1 May 2018
31 Dec 2017$186.0M—20 Feb 2018
30 Sep 2017$154.0M—2 Nov 2017
30 Jun 2017$154.0M—3 Aug 2017
31 Mar 2017$141.0M—3 May 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Boston Scientific: Interventional Cardiology & Vascular Therapies revenue · Electrophysiology revenue · Endoscopy revenue · Peripheral Interventions revenue · Urology revenue · Cardiac Rhythm Management revenue · Watchman revenue · Interventional Oncology & Embolization revenue · Cardiology revenue · Cardiovascular revenue · MedSurg revenue · United States revenue · Int'l revenue · Emerging Markets revenue · financial statements

Every KPI and segment of BSX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.